NPS Pharmaceuticals Inc (NPSP)

45.97
0.01 0.02
Prev Close 45.96
Open 45.96
Day Low/High 45.95 / 45.99
52 Wk Low/High 22.11 / 46.01
Volume 9.49M
Avg Volume 4.75M
Exchange
Shares Outstanding 108.58M
Market Cap 4.99B
EPS -0.08
Div & Yield N.A. (N.A)
European Stocks Rebound as Pharma Deals Renew Confidence

European Stocks Rebound as Pharma Deals Renew Confidence

European markets rebound on Monday, as news of a series of pharma industry deals seemed to indicate a renewal of confidence after last week's falls.

Five Things to Know Now: Pharma Mergers

Pharma mergers boost stocks.

Cramer: Hold Your Fire

There isn't a lot of good news around.

Tale of 2 Rare Disease Stocks: Aegerion, NPS Pharmaceuticals

Tale of 2 Rare Disease Stocks: Aegerion, NPS Pharmaceuticals

A successful rare-disease drug launch and the development of a second product made NPS an attractive takeout target.

Shire to buy specialty drugmaker NPS Pharma for $5.2 billion

Shire to buy specialty drugmaker NPS Pharma for $5.2 billion

Irish drugmaker Shire PLC SHPG said Sunday it will pay $5.2 billion to acquire NPS Pharmaceuticals NPSP, which specializes in drugs for rare conditions.

Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1

Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1

The much ballyhooed J.P. Morgan Healthcare Conference kicks off Monday in San Francisco. Here are capsule summaries of some of the expected story lines from presenting companies.

Orphan Drug Company NPS Pharmaceuticals May Find Few Buyers

Orphan Drug Company NPS Pharmaceuticals May Find Few Buyers

Shire has cash for what could be a $5 billion deal, but treatment base is limited.

NPS Pharma To Present At J.P. Morgan Healthcare Conference

NPS Pharma To Present At J.P. Morgan Healthcare Conference

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is scheduled to present at the 33 rd Annual J.

Barbarian At The Gate: NPS Pharmaceuticals (NPSP)

Barbarian At The Gate: NPS Pharmaceuticals (NPSP)

Trade-Ideas LLC identified NPS Pharmaceuticals (NPSP) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Fibocall: NPS Pharmaceuticals

Fibocall: NPS Pharmaceuticals

 A new spike came on Wednesday, triggering an alert.

NPS Pharmaceuticals (NPSP) Marked As A Barbarian At The Gate

NPS Pharmaceuticals (NPSP) Marked As A Barbarian At The Gate

Trade-Ideas LLC identified NPS Pharmaceuticals (NPSP) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

NPS Pharma To Present At Oppenheimer Healthcare Conference

NPS Pharma To Present At Oppenheimer Healthcare Conference

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is scheduled to present at the Oppenheimer 25 th Annual Healthcare Conference in New York on Thursday, December 11, 2014 at 9:45 a.

Today's Perilous Reversal Stock: NPS Pharmaceuticals (NPSP)

Today's Perilous Reversal Stock: NPS Pharmaceuticals (NPSP)

Trade-Ideas LLC identified NPS Pharmaceuticals (NPSP) as a "perilous reversal" (up big yesterday but down big today) candidate

European Medicines Agency Validates Marketing Authorization Application For Natpar® (parathyroid Hormone (rDNA)) In Hypoparathyroidism

European Medicines Agency Validates Marketing Authorization Application For Natpar® (parathyroid Hormone (rDNA)) In Hypoparathyroidism

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the European Medicines ...

NPS Pharma To Present At Deutsche Bank BioFEST Conference

NPS Pharma To Present At Deutsche Bank BioFEST Conference

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is scheduled to present at the 2014 Deutsche Bank BioFEST Conference in Boston on Tuesday, December 2, 2014 at 9:55 a.

Teduglutide Granted Orphan Drug Designation In Japan

Teduglutide Granted Orphan Drug Designation In Japan

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the Japanese Ministry of...

Insider Trading Alert - AKAM, NPSP And FNFG Traded By Insiders

Insider Trading Alert - AKAM, NPSP And FNFG Traded By Insiders

Stocks with insider trader activity include AKAM, NPSP and FNFG

NPS Pharma To Present At Jefferies Global Healthcare Conference

NPS Pharma To Present At Jefferies Global Healthcare Conference

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is scheduled to present at the Jefferies 2014 Global Healthcare Conference in London on Thursday, November 20, 2014 at 8:00 a.

Barbarian At The Gate: NPS Pharmaceuticals (NPSP)

Barbarian At The Gate: NPS Pharmaceuticals (NPSP)

Trade-Ideas LLC identified NPS Pharmaceuticals (NPSP) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

NPS Pharma Reports Third-Quarter 2014 Financial Results

NPS Pharma Reports Third-Quarter 2014 Financial Results

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering innovative therapies that transform the lives of patients with rare diseases, today reported its results for the...

Insider Trading Alert - NPSP, GPI And JDSU Traded By Insiders

Insider Trading Alert - NPSP, GPI And JDSU Traded By Insiders

Stocks with insider trader activity include NPSP, GPI and JDSU

NPS Pharma Appoints Pierre Legault To Board Of Directors

NPS Pharma Appoints Pierre Legault To Board Of Directors

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced the appointment of Pierre ...

NPS Pharma To Report Third Quarter 2014 Financial Results

NPS Pharma To Report Third Quarter 2014 Financial Results

NPS Pharmaceuticals, Inc. (Nasdaq:NPSP) announced today that it will report its third quarter 2014 financial results on Monday, November 10, 2014 at approximately 4:00 p.

Insider Trading Alert - NPSP, CB And SPLK Traded By Insiders

Insider Trading Alert - NPSP, CB And SPLK Traded By Insiders

Stocks with insider trader activity include NPSP, CB and SPLK

Perilous Reversal Watch: NPS Pharmaceuticals (NPSP)

Perilous Reversal Watch: NPS Pharmaceuticals (NPSP)

Trade-Ideas LLC identified NPS Pharmaceuticals (NPSP) as a "perilous reversal" (up big yesterday but down big today) candidate

PDUFA Action Date For Natpara® BLA Extended Three Months To January 24, 2015

PDUFA Action Date For Natpara® BLA Extended Three Months To January 24, 2015

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today reported that the U.

Some Potential Targets for Shire to Buy With $1.6B in Free Money

Some Potential Targets for Shire to Buy With $1.6B in Free Money

Shire isn't obligated to spend AbbVie's money, but it's no fun speculating about earned interest. Which drug companies might be takeout targets for Shire?

NPS Pharmaceuticals (NPSP) Showing Signs Of A Dead Cat Bounce Today

NPS Pharmaceuticals (NPSP) Showing Signs Of A Dead Cat Bounce Today

Trade-Ideas LLC identified NPS Pharmaceuticals (NPSP) as a "dead cat bounce" (down big yesterday but up big today) candidate

NPS Pharma To Present At Leerink Partners Rare Disease Roundtable

NPS Pharma To Present At Leerink Partners Rare Disease Roundtable

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the Leerink Partners Rare Disease Roundtable in New York on Wednesday, October 1, 2014 at 2:45 p.

How to Trade the Market's Most-Active Stocks: RATE, AVNR, NPSP, TAP

How to Trade the Market's Most-Active Stocks: RATE, AVNR, NPSP, TAP

Here's a look at how to trade some of the most active stocks on the market right now.